Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
74
BMED Quote, Financials, Valuation and Earnings
Last price:
$30.51
Seasonality move
:
5.99%
Day range:
$30.51 - $30.53
52-week range:
$20.57 - $30.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
368
Avg. volume:
3.2K
1-year change:
18.05%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
$30.51 | -- | -- | -- | $0.01 | 0% | -- |
|
CANC
Tema Oncology ETF
|
$35.09 | -- | -- | -- | $0.73 | 1.42% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$96.67 | -- | -- | -- | $0.76 | 1.43% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$58.01 | -- | -- | -- | $0.33 | 4.86% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | 0.918 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 0.905 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.388 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.523 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
iShares Health Innovation Active ETF vs. Competitors
-
Which has Higher Returns BMED or CANC?
Tema Oncology ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About BMED or CANC?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than Tema Oncology ETF, analysts believe iShares Health Innovation Active ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is BMED or CANC More Risky?
iShares Health Innovation Active ETF has a beta of 0.901, which suggesting that the stock is 9.904% less volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or CANC?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Tema Oncology ETF offers a yield of 1.42% to investors and pays a quarterly dividend of $0.73 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or CANC?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns BMED or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About BMED or IXJ?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe iShares Health Innovation Active ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is BMED or IXJ More Risky?
iShares Health Innovation Active ETF has a beta of 0.901, which suggesting that the stock is 9.904% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.669, suggesting its less volatile than the S&P 500 by 33.078%.
-
Which is a Better Dividend Stock BMED or IXJ?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. iShares Global Healthcare ETF offers a yield of 1.43% to investors and pays a quarterly dividend of $0.76 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or IXJ?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns BMED or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About BMED or JDOC?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe iShares Health Innovation Active ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is BMED or JDOC More Risky?
iShares Health Innovation Active ETF has a beta of 0.901, which suggesting that the stock is 9.904% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or JDOC?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. JPMorgan Healthcare Leaders ETF offers a yield of 4.86% to investors and pays a quarterly dividend of $0.33 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or JDOC?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 62.68% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.8% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.82% over the past day.
